CliffBio
small molecule

AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE

AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameAZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE
Active ingredientAZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE
Strength0.137MG/SPRAY;0.05MG/SPRAY
Dosage formSPRAY, METERED
RouteNASAL
ModalitySmall molecule
FDA approvalApril 2017
Marketing statusRX

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.